SH
Shuttle Pharmaceuticals Holdings, Inc.
SHPH · NASDAQ
$3.49 +5.28% (+$0.18)
1M -14.63%
Market Cap $1.98M
P/E Ratio -
Div. Yield -
ROE 408.33%
Bulios Fair Price
$5.11
46.4% upside
Current Price
$3.49
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SHPH is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.59x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 33.53%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 312.04%
ROE 408.33%
ROA 91.63%
Debt
46 /100
Moderate Debt/Equity 0.06x
Current ratio 0.30x
Int. coverage -151.37x
Stability
22 /100
Unstable Beta 1.22x
EPS volatility 124,686.30%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SHPH
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Christopher Robert Cooper
Employees
2
Headquarters
Gaithersburg